| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/26/2001 | WO2001053259A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001052855A2 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 07/26/2001 | WO2001052853A1 Anxiety method |
| 07/26/2001 | US20010009962 One pot process for preparing sildenafil (drug for erectile dysfunction) and derivatives by reacting for example 4-(2-methoxy-5-(4-methyl-1-piperazinylsulfonyl)benzamido)-1-methyl-3-propyl -1H-pyrazole-5-carboxamide with ethanol |
| 07/26/2001 | US20010009921 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/26/2001 | US20010009915 Nitrogen oxide yielding and thromboxane A2 (TXA2) and serotonin (5HT2) receptor antagonist; treatment of atherothrombotic cardiovascular disorders |
| 07/26/2001 | US20010009911 Isomers, hydrates, solvates and addition salts in treatment of endothelial dysfunction disease such as atherosclerosis, dyslipidaemia; antidiabetic agents; heart transplantation; inhibition of nitrogen monoxide synthase and oxidative stress |
| 07/26/2001 | CA2406732A1 Anxiety method |
| 07/26/2001 | CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 07/26/2001 | CA2398388A1 Novel piperidine compound and pharmaceutical thereof |
| 07/26/2001 | CA2397665A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397008A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 07/26/2001 | CA2396066A1 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 07/26/2001 | CA2394703A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | CA2388885A1 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 07/25/2001 | EP1118610A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/25/2001 | EP1118323A2 Method of reducing morbidity and the risk of mortality |
| 07/25/2001 | EP1118322A1 Drugs for improving vesical excretory strength |
| 07/25/2001 | EP1117663A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 07/25/2001 | EP1117662A1 Benzimidazolinyl piperidines as cgrp ligands |
| 07/25/2001 | EP1117661A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 07/25/2001 | EP1117659A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/25/2001 | EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 07/25/2001 | EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 07/25/2001 | EP1117654A1 Sulfonyltriazol derivatives and their use for combating micro-organisms |
| 07/25/2001 | EP1117653A1 Chemical compounds |
| 07/25/2001 | EP1117652A1 Tan-1057 derivatives |
| 07/25/2001 | EP1117651A1 New bis-benzimidazoles |
| 07/25/2001 | EP1117650A2 Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for the production thereof and agents containing the same |
| 07/25/2001 | EP1117649A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/25/2001 | EP1117642A1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 07/25/2001 | EP1117406A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117372A2 Method of treating hair loss using sulfonamides |
| 07/25/2001 | EP1117371A2 Method of treating hair loss using ketoamides |
| 07/25/2001 | EP0966445B1 Processes for preparing pesticidal intermediates |
| 07/25/2001 | EP0876346B1 Antimalarial quinolin derivatives |
| 07/25/2001 | EP0873319B1 Quinazoline derivatives |
| 07/25/2001 | EP0677049B1 Quinazoline derivatives |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305472A Novel 2,5-pyridinedicarboxylic acid derivatives |
| 07/25/2001 | CN1305471A Dihydropyrimidines |
| 07/25/2001 | CN1305470A Amidine compounds |
| 07/25/2001 | CN1305467A Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305462A Novel 1,5 and 3-O-substituted 1H-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, and method for the production and use thereof as medica |
| 07/25/2001 | CN1304936A Quinoline-4-radical derivative II |
| 07/25/2001 | CN1304932A Intermediate for preparing 1,4-disubstituted tetraazolequinolinone |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1068882C Process for preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds |
| 07/25/2001 | CN1068881C Phenyl-oxo-alkyl-(4-pieridinyl) benzoate derivs |
| 07/25/2001 | CN1068878C Sulfonamide derivatives of azolones anti-helicobacter agents |
| 07/25/2001 | CN1068876C Process for preparing chiral succinic acid derivatives |
| 07/24/2001 | US6265581 Reacting specified epoxide and amine, reacting product with acid to form acid addition salt |
| 07/24/2001 | US6265473 Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265426 Triazole derivatives |
| 07/24/2001 | US6265422 Anticancer agents; cardiovascular disorders |
| 07/24/2001 | US6265421 Phospholamban inhibitors and a method for increasing coronary flow |
| 07/24/2001 | US6265414 Treating sleep disorders using desloratadine |
| 07/24/2001 | US6265411 Oxindole derivatives |
| 07/24/2001 | US6265408 Sulphonamide derivatives and their use in the treatment of CNS disorders |
| 07/24/2001 | US6265404 Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
| 07/24/2001 | US6265352 Substituted carbamoyl triazoles and their use as herbicides |
| 07/24/2001 | US6265349 Pyridone derivatives and herbicides |
| 07/24/2001 | US6265348 Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 07/24/2001 | US6265127 1, 4-dihydrophyridine charge control agents for electrostatographic toners and developers |
| 07/24/2001 | CA2331847A1 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 07/24/2001 | CA2218503C Arylsulfonyl hydroxamic acid derivatives |
| 07/24/2001 | CA2171972C Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 07/24/2001 | CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents |
| 07/19/2001 | WO2001051484A1 Benzimidazole derivatives and their use as factor xa inhibitors |
| 07/19/2001 | WO2001051479A2 Tricyclic compounds with antiviral activity |
| 07/19/2001 | WO2001051473A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 07/19/2001 | WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists |
| 07/19/2001 | WO2001051468A1 4-aminopicolinates and their use as herbicides |
| 07/19/2001 | WO2001051050A1 Novel substituted benzimidazole dosage forms and method of using same |
| 07/19/2001 | WO2001044172A8 Salicylamides as serine protease and factor xa inhibitors |
| 07/19/2001 | WO2001005762A3 Biphenyl derivatives, production thereof and use as mtp inhibitors |
| 07/19/2001 | WO2001005758A3 Indoles and indazoles for the treatment of migraine |
| 07/19/2001 | WO2001004090A3 Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods |
| 07/19/2001 | WO2001002345A3 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 07/19/2001 | WO2000076984A8 Novel compounds, their use and preparation |
| 07/19/2001 | WO2000076970A3 Serine protease inhibitors |
| 07/19/2001 | WO2000076966A3 Indolinylamide derivatives and the use thereof as antiviral drugs |
| 07/19/2001 | US20010008938 Process for preparation of sulfonylurea salts |
| 07/19/2001 | US20010008899 Administering (-) pantoprazole, or a pharmaceutically acceptable salt thereof, substantially free of its (+) stereoisomer; treatment of ulcers |
| 07/19/2001 | US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/19/2001 | CA2396560A1 Tricyclic compounds and method of treating herpes virus |
| 07/19/2001 | CA2396007A1 Piperidine and piperazine derivatives |
| 07/18/2001 | EP1116717A1 Substituted 3-phenylpyrazoles as herbicides |
| 07/18/2001 | EP1116716A1 Piperidine and piperazine compounds for use in the treatment of Alzheimer |
| 07/18/2001 | EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 07/18/2001 | EP1115721A1 Pyrimidone derivatives |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115704A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
| 07/18/2001 | EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors |